Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Buprenorphine for Cancer Pain: Evidence, Guidelines, and Clinical Rationale for Early Use.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Recurrent basosquamous carcinoma of the forearm, a case report.

JPRAS open·2026
Same author

Secondary metabolites from the endophytic fungus Trichoderma afroharzianum and their cytotoxic activities.

Fitoterapia·2026
Same author

Implementation of Structured Oncologist Communication Skills Training within the Improving Goal Concordant Care Initiative: Lessons Learned and Future Progress.

Journal of palliative medicine·2026
Same author

Generative Artificial Intelligence Use in the Peer Review Process.

Journal of pain and symptom management·2026
Same author

Engineering prime editors in Salvia miltiorrhiza for precise genome modification.

Journal of integrative plant biology·2026
Same journal

Glucagon-like peptide-1 improves vascular endothelial dysfunction in hypertensive mice via CREB-driven transcriptional regulation of long non-coding RNA 155383.

British journal of pharmacology·2026
Same journal

The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling.

British journal of pharmacology·2026
Same journal

Peripheral targets for neuropathic pain.

British journal of pharmacology·2026
Same journal

Therapeutic potential of liver X receptor agonist GW3965 in preserving myelin integrity following traumatic brain injury.

British journal of pharmacology·2026
Same journal

The role of protein arginine methyltransferases in sickle cell-mediated neurovascular impairments in mice.

British journal of pharmacology·2026
Same journal

β-Cyclodextrin inclusion enhances the pro-resolving effects of the annexin A1 mimetic Ac2-26 in a mouse model of antigen-induced arthritis.

British journal of pharmacology·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

10.0K

Cancer pain: current practice and emerging targets.

Yi Ye1,2,3, Marcin Chwistek4, Zhiting Gong1,2

  • 1Translational Research Center, Department of Oral & Maxillofacial Surgery, College of Dentistry, New York University, New York, New York, USA.

British Journal of Pharmacology
|April 4, 2026
PubMed
Summary
This summary is machine-generated.

Cancer pain involves complex tumor-nerve-immune interactions. Future treatments will focus on personalized, mechanism-driven therapies targeting these pathways, moving beyond current NSAIDs and opioids.

Keywords:
aberrant pain signallingcancer neurosciencecancer painresiniferatoxintumor microenvironment

More Related Videos

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.8K
Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

10.1K

Related Experiment Videos

Last Updated: Apr 5, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

10.0K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.8K
Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

10.1K

Area of Science:

  • Oncology
  • Neuroscience
  • Pain Management

Background:

  • Cancer pain (CP) results from tumor-microenvironment interactions, often presenting as mixed nociceptive, neuropathic, and neuroinflammatory pain.
  • Current CP management relies heavily on non-steroidal anti-inflammatory drugs (NSAIDs) and opioids, despite limited efficacy for complex pain phenotypes.
  • Recent cancer neuroscience research reveals CP involves aberrant crosstalk between tumors, sensory nerves, and attracted immune cells.

Purpose of the Study:

  • To review current cancer pain management strategies.
  • To explore emerging personalized, mechanism-driven therapies for cancer pain.
  • To highlight advances in understanding the neurobiology of cancer pain.

Main Methods:

  • Review of current literature on cancer pain management.
  • Analysis of recent findings in cancer neuroscience and pain signaling.
  • Discussion of novel molecular mechanisms and precision approaches.

Main Results:

  • Cancer pain is characterized by complex neuro-immune interactions.
  • Emerging therapies aim to disrupt aberrant pain signaling cascades.
  • Personalized, mechanism-driven approaches offer future treatment potential.

Conclusions:

  • Cancer pain management is evolving beyond traditional treatments.
  • Understanding the neurobiology of CP is crucial for developing targeted therapies.
  • Precision oncology will guide future personalized cancer pain interventions.